Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F88RS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,473
Award facts
- Contract value 100% obligated
- $13,473.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,473.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 5 mg/0.5 mL pens on February 3, 2026, with completion by February 4, 2026. This non-set-aside competitive award will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle running through December 2031 that serves as the primary mechanism for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical vendor with extensive experience fulfilling Defense Logistics Agency procurement requirements. The company's capabilities span a comprehensive portfolio of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This award for Zepbound—a diabetes and weight management medication—reflects the contractor's ongoing role in supplying essential pharmaceutical commodities to military treatment facilities and other federal healthcare systems as part of the DLA's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26F88RS?
SPE2DR26F88RS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 3, 2026.
How much is contract SPE2DR26F88RS worth?
The government has obligated $13,473 on SPE2DR26F88RS.
Is contract SPE2DR26F88RS an order under another contract?
Yes. SPE2DR26F88RS is a delivery order under SPE2DR25D3010, an indefinite delivery contract.
Was contract SPE2DR26F88RS competed?
The extent of competition for SPE2DR26F88RS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award